What are the side effects of clonazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Side Effects of Clonazepam

Clonazepam commonly causes drowsiness (approximately 50% of patients), problems with walking and coordination/ataxia (approximately 30%), dizziness, depression, fatigue, and memory problems. 1

Most Common Side Effects

The FDA-approved labeling and clinical guidelines consistently identify these primary adverse effects 1:

  • Drowsiness/Somnolence - occurs in ~50% of seizure patients and 7% discontinue panic disorder treatment due to this
  • Ataxia and coordination problems - affects ~30% of patients; particularly concerning for falls
  • Dizziness
  • Depression - 4% of panic disorder patients discontinue due to this
  • Fatigue and weakness
  • Memory problems and cognitive impairment - including amnesia and reduced intellectual ability

Serious and Concerning Side Effects

In Older Adults and Neurodegenerative Disease Patients

Clonazepam poses particularly high risks in older adults and should be used with extreme caution. The 2023 American Academy of Sleep Medicine guideline specifically warns that concerning side effects include 2:

  • Morning sedation
  • Gait imbalance and falls risk
  • Cognitive disturbances, specifically delirium and amnesia
  • Depression
  • Exacerbation of sleep-disordered breathing

The guideline notes that clonazepam is listed on the American Geriatrics Society Beers Criteria as a potentially inappropriate medication in older adults 2. Among patients with neurodegenerative diseases like Parkinson's or dementia, progressive cognitive decline combined with age-related impairments in drug metabolism often leads to gradual intolerance, even at lower starting doses of 0.25 mg 2.

Behavioral and Psychiatric Effects

Behavioral problems occur in approximately 25% of patients 1. Paradoxical reactions can occur, including 1:

  • Irritability, aggression, and agitation
  • Nervousness, hostility, and anxiety
  • Sleep disturbances and nightmares
  • Hallucinations
  • Confusion and psychosis (more likely in patients with psychiatric history)

Respiratory Depression

When combined with opioids, clonazepam can cause severe drowsiness, respiratory depression, coma, and death 1. This represents a critical drug interaction that must be avoided.

Dependence and Withdrawal

Clonazepam causes physical dependence and tolerance with prolonged use, and abrupt discontinuation can trigger life-threatening seizures (status epilepticus) 1, 3. The FDA labeling explicitly warns that stopping suddenly can cause 1:

  • Seizures that will not stop (status epilepticus)
  • Hallucinations
  • Shaking and tremors
  • Stomach and muscle cramps

Research demonstrates that discontinuation symptoms during gradual tapering are typically mild and include anxiety, tremor, nausea, insomnia, excessive sweating, tachycardia, headache, weakness, and muscle aches 4. However, these symptoms only remain mild when the medication is tapered very slowly (0.25 mg per week after reaching 1 mg/day) 4.

Less Common but Notable Side Effects

Additional adverse effects reported in clinical trials include 1:

  • Respiratory: Chest congestion, shortness of breath, hypersecretion
  • Gastrointestinal: Nausea, changes in appetite
  • Genitourinary: Dysuria, urinary retention
  • Hematologic: Anemia, leukopenia, thrombocytopenia
  • Hepatic: Elevated liver enzymes
  • Neurologic: Diplopia, dysarthria, nystagmus, vertigo, headache
  • Other: Weight changes, fever

Clinical Context

The side effect profile varies somewhat by indication. In panic disorder trials, 17% of patients discontinued due to adverse events compared to 9% on placebo 1. The most effective doses (1-2 mg daily) offered the best balance of therapeutic benefit and tolerability 5.

The key clinical pitfall is underestimating the cognitive and motor impairment risks, particularly in older adults, and failing to taper slowly enough when discontinuing. Patients must be explicitly warned not to drive or operate machinery until they know how the medication affects them, and to avoid alcohol and other CNS depressants 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.